Proqr Therapeutics Bv Stock Market Value

PRQR Stock  USD 2.01  0.01  0.50%   
ProQR Therapeutics' market value is the price at which a share of ProQR Therapeutics trades on a public exchange. It measures the collective expectations of ProQR Therapeutics BV investors about its performance. ProQR Therapeutics is selling at 2.01 as of the 25th of April 2024; that is -0.5 percent decrease since the beginning of the trading day. The stock's lowest day price was 1.97.
With this module, you can estimate the performance of a buy and hold strategy of ProQR Therapeutics BV and determine expected loss or profit from investing in ProQR Therapeutics over a given investment horizon. Check out ProQR Therapeutics Correlation, ProQR Therapeutics Volatility and ProQR Therapeutics Alpha and Beta module to complement your research on ProQR Therapeutics.
Symbol

ProQR Therapeutics Price To Book Ratio

Is ProQR Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProQR Therapeutics. If investors know ProQR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProQR Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.37)
Revenue Per Share
0.081
Quarterly Revenue Growth
1.712
Return On Assets
(0.14)
Return On Equity
(0.51)
The market value of ProQR Therapeutics is measured differently than its book value, which is the value of ProQR that is recorded on the company's balance sheet. Investors also form their own opinion of ProQR Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is ProQR Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProQR Therapeutics' market value can be influenced by many factors that don't directly affect ProQR Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProQR Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProQR Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProQR Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

ProQR Therapeutics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ProQR Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ProQR Therapeutics.
0.00
05/06/2022
No Change 0.00  0.0 
In 1 year 11 months and 21 days
04/25/2024
0.00
If you would invest  0.00  in ProQR Therapeutics on May 6, 2022 and sell it all today you would earn a total of 0.00 from holding ProQR Therapeutics BV or generate 0.0% return on investment in ProQR Therapeutics over 720 days. ProQR Therapeutics is related to or competes with AnnexonInc, Arrowhead Pharmaceuticals, Day One, Terns Pharmaceuticals, Alnylam Pharmaceuticals, Wave Life, and Blueprint Medicines. ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics... More

ProQR Therapeutics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ProQR Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ProQR Therapeutics BV upside and downside potential and time the market with a certain degree of confidence.

ProQR Therapeutics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for ProQR Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ProQR Therapeutics' standard deviation. In reality, there are many statistical measures that can use ProQR Therapeutics historical prices to predict the future ProQR Therapeutics' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ProQR Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.102.026.17
Details
Intrinsic
Valuation
LowRealHigh
0.122.436.58
Details
Naive
Forecast
LowNextHigh
0.042.146.29
Details
6 Analysts
Consensus
LowTargetHigh
3.583.934.36
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as ProQR Therapeutics. Your research has to be compared to or analyzed against ProQR Therapeutics' peers to derive any actionable benefits. When done correctly, ProQR Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in ProQR Therapeutics.

ProQR Therapeutics Backtested Returns

We consider ProQR Therapeutics very risky. ProQR Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0066, which implies the firm had a 0.0066% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for ProQR Therapeutics, which you can use to evaluate the volatility of the company. Please check ProQR Therapeutics' Semi Deviation of 3.56, coefficient of variation of 10674.45, and Risk Adjusted Performance of 0.0143 to confirm if the risk estimate we provide is consistent with the expected return of 0.0274%. The company holds a Beta of 1.48, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ProQR Therapeutics will likely underperform. ProQR Therapeutics right now holds a risk of 4.15%. Please check ProQR Therapeutics potential upside, as well as the relationship between the accumulation distribution and relative strength index , to decide if ProQR Therapeutics will be following its historical price patterns.

Auto-correlation

    
  0.68  

Good predictability

ProQR Therapeutics BV has good predictability. Overlapping area represents the amount of predictability between ProQR Therapeutics time series from 6th of May 2022 to 1st of May 2023 and 1st of May 2023 to 25th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ProQR Therapeutics price movement. The serial correlation of 0.68 indicates that around 68.0% of current ProQR Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient0.68
Spearman Rank Test0.47
Residual Average0.0
Price Variance0.11

ProQR Therapeutics lagged returns against current returns

Autocorrelation, which is ProQR Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ProQR Therapeutics' stock expected returns. We can calculate the autocorrelation of ProQR Therapeutics returns to help us make a trade decision. For example, suppose you find that ProQR Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

ProQR Therapeutics regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ProQR Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ProQR Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ProQR Therapeutics stock over time.
   Current vs Lagged Prices   
       Timeline  

ProQR Therapeutics Lagged Returns

When evaluating ProQR Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ProQR Therapeutics stock have on its future price. ProQR Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ProQR Therapeutics autocorrelation shows the relationship between ProQR Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in ProQR Therapeutics BV.
   Regressed Prices   
       Timeline  

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ProQR Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ProQR Therapeutics' short interest history, or implied volatility extrapolated from ProQR Therapeutics options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as ProQR Therapeutics using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether ProQR Therapeutics is a strong investment it is important to analyze ProQR Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ProQR Therapeutics' future performance. For an informed investment choice regarding ProQR Stock, refer to the following important reports:
Check out ProQR Therapeutics Correlation, ProQR Therapeutics Volatility and ProQR Therapeutics Alpha and Beta module to complement your research on ProQR Therapeutics.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Complementary Tools for ProQR Stock analysis

When running ProQR Therapeutics' price analysis, check to measure ProQR Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProQR Therapeutics is operating at the current time. Most of ProQR Therapeutics' value examination focuses on studying past and present price action to predict the probability of ProQR Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProQR Therapeutics' price. Additionally, you may evaluate how the addition of ProQR Therapeutics to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Transaction History
View history of all your transactions and understand their impact on performance
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
ProQR Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of ProQR Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of ProQR Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...